Gaëlle Fromont-hankard

Title: Gaëlle Fromont-Hankard: Innovator in Prostate Cancer Research

Introduction

Gaëlle Fromont-Hankard is a notable inventor based in Luynes, France. He has made significant contributions to the field of medical research, particularly in the area of prostate cancer. His innovative work focuses on developing methods for predicting cancer recurrence, which can greatly impact patient care and treatment strategies.

Latest Patents

Gaëlle Fromont-Hankard holds a patent titled "Molecular signature and use thereof for the identification of indolent prostate cancer." This patent describes a method for predicting the risk of prostate cancer recurrence in affected individuals. The process involves providing a sample from the subject, determining the TMPRSS/ERG fusion status, and measuring the expression levels of specific prostate cancer markers. By comparing the molecular signature to a reference signature, the method assigns the subject to a risk group, thereby predicting the likelihood of cancer recurrence.

Career Highlights

Throughout his career, Gaëlle Fromont-Hankard has worked with prestigious institutions such as Sorbonne Université and the Centre de Recherche Pathologies Prostatiques. His research has contributed to advancements in understanding prostate cancer and improving diagnostic methods.

Collaborations

Some of his notable coworkers include Olivier Cussenot and Aurélie Kamoun. Their collaborative efforts have furthered research in the field of prostate cancer, enhancing the understanding of molecular signatures and their implications for patient outcomes.

Conclusion

Gaëlle Fromont-Hankard's innovative work in prostate cancer research exemplifies the importance of scientific advancements in improving patient care. His contributions through patents and collaborations continue to influence the medical community and offer hope for better cancer management strategies.